Nanomedicine (Lincoln)

Code

MEDS3067

School

Medical Education Centre

Level

3

Credits

10

Semesters

Spring UK

Summary

Nanomedicine studies the application in medicine of nanomaterials for therapeutic and diagnostic purpose. The module addresses basic principles of nanoscience and provides an overview of up-to-date pre-clinical and clinical research that makes use of nanotechnology, such as the delivery of nanoparticle-bound drugs for cancer therapy.

The module includes introductory lectures to provide information to help students gain basic understanding of the nanoscience principles behind the use of nanomaterials in medicine. 

Specific and relevant examples on the application of nanotechnology to pre-clinical and clinical research will be communicated in a series of seminars. Examples of topics covered in lectures and seminars are: methods and materials in nanomedicine, drug delivery via nano-formulation and nano-carriers, bio-accumulation and intracellular trafficking of nanomaterials, nanoparticles for medical imaging and theragnostics, nanotoxicity and interaction between nanoparticles and blood plasma. 

The understanding of the interaction between biomolecules and nanomaterials will be supported by hands-on activities in the form of a workshop and a laboratory session, which will contribute to advance students’ numeracy and practical skills respectively.
 

Target Students

Year 2 students registered on the BMedSci based in Lincoln (A10L). There is a limited number of places on this module. Students are reminded that enrolments which are not agreed by the Offering School in advance may be cancelled without notice.

Classes

• One 2-hour workshop
• One 1-hour seminar each week for 5 weeks
• One 3-hour practicum
• One 1-hour lecture each week for 3 weeks

3x1hr lectures, 1x3 hr laboratory practical, 5x1hr seminars, 1x2hr workshop. Student-Led: 87 hours.

Assessment

• 100% Coursework 1: 2,000 word Practical report

Assessed by end of spring semester

Educational Aims

Learning Outcomes

The students will achieve learning outcomes within the GMC’s Outcomes for Graduates (2018) as follows: 
(for “Newly qualified doctors” read “Students”) 

22 Newly qualified doctors must be able to apply biomedical scientific principles, methods and knowledge to medical practice and integrate these into patient care. This must include principles and knowledge relating to anatomy, biochemistry, cell biology, genetics, genomics and personalised medicine, immunology, microbiology, molecular biology, nutrition, pathology, pharmacology and clinical pharmacology, and physiology.
They must be able to:

e.  Describe medications and medication actions: therapeutics and pharmacokinetics; medication side effects and interactions, including for multiple treatments, long term physical and mental conditions and non-prescribed drugs; the role of pharmacogenomics and antimicrobial stewardship
 

26 Newly qualified doctors must be able to apply scientific method and approaches to medical research and integrate these with a range of sources of information used to make decisions for care.
They must be able to:

c.  Describe the role and value of qualitative and quantitative methodological approaches to scientific enquiry.  Critically appraise a range of research information including study design, the results of relevant diagnostic, prognostic and treatment trials, and other qualitative and quantitative studies as reported in the medical and scientific literature.f.  Formulate simple relevant research questions in biomedical science, psychosocial science or population science, and design appropriate studies or experiments to address the question

Conveners

• Professor David O'Brien